Close

Analyst Ratings for NextCure Inc. (NXTC) [Neutrals]

NXTC Rating Summary

NXTC Price Target Summary

* Over Last 12-Mos
  |   Expand Research on NXTC
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $8.00 (+455.6%) * Over Last 12-Mos
Rating Score: 5.5 / 10   Percentile Rank: 59%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/4/2022 Ladenburg Thalmann Aydin Huseynov Downgrade Neutral
(Buy)
N/A
(N/A)
2.51
(1.44)
-42.63% Details
7/13/2020 Morgan Stanley N/A Downgrade Equalweight
(Overweight)
11.00
(N/A)
17.88
(1.44)
-91.95% Details